The ongoing struggle against drug trafficking has once again come into focus as U.S. President Donald Trump calls for more rigorous efforts from Mexico. In a recent presidential determination sent to Congress, Trump commended Mexican President Claudia Sheinbaum’s administration for its progress, citing increased drug seizures and the dismantling of clandestine laboratories. However, he emphasized that these efforts are not enough to effectively combat the pervasive influence of drug cartels.
Trump’s remarks highlight the persistent challenges in managing drug-related crime across the U.S.-Mexico border. He urged Mexico to bolster its actions against drug-trafficking organizations and their financial networks, stressing the need for a more aggressive stance. According to Trump, identifying, arresting, and prosecuting public officials who are allegedly assisting these criminal organizations is crucial for dismantling the infrastructure that supports drug trafficking.
Despite acknowledging the improvements under Sheinbaum’s leadership, Trump insists that stronger enforcement is vital. He pointed out that Mexican territory, which serves as a significant conduit for illegal drugs, requires increased security measures to disrupt the operations of these organizations effectively.
In addition to Mexico, the U.S. government has identified other countries as major drug-transit or illicit drug-producing nations. This list includes Canada and extends to several Central American and Caribbean countries like Guatemala, Honduras, El Salvador, Haiti, the Dominican Republic, Jamaica, and Belize. These nations are considered part of the broader international drug-trafficking routes that pose challenges for regional security and law enforcement.